T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05576532	Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia	unknown	Phase 2	30	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Jun 28, 2023	clinicaltrials
NCT04762485	Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia	unknown	Phase 1 / Phase 2	20	The First Affiliated Hospital of Soochow UniversityOTHER	1	Jun 2, 2021